Cargando…

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis

OBJECTIVE: To compare the efficacy, safety, and cost effectiveness of direct acting oral anticoagulants (DOACs) for patients with atrial fibrillation. DESIGN: Systematic review, network meta-analysis, and cost effectiveness analysis. DATA SOURCES: Medline, PreMedline, Embase, and The Cochrane Librar...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-López, José A, Sterne, Jonathan A C, Thom, Howard H Z, Higgins, Julian P T, Hingorani, Aroon D, Okoli, George N, Davies, Philippa A, Bodalia, Pritesh N, Bryden, Peter A, Welton, Nicky J, Hollingworth, William, Caldwell, Deborah M, Savović, Jelena, Dias, Sofia, Salisbury, Chris, Eaton, Diane, Stephens-Boal, Annya, Sofat, Reecha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704695/ https://www.ncbi.nlm.nih.gov/pubmed/29183961 http://dx.doi.org/10.1136/bmj.j5058

Ejemplares similares

Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis
por: Thom, Howard H. Z., et al.
Publicado: (2019)

Development of a method for adjusting trial results for biases in meta-analysis
por: Turner, Rebecca, et al.
Publicado: (2013)

Translating genomics into improved healthcare
por: Hingorani, Aroon D, et al.
Publicado: (2010)

Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular Degeneration: A Mendelian Randomization Study
por: Kuan, Valerie, et al.
Publicado: (2021)

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
por: Sofat, Reecha, et al.
Publicado: (2012)

Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three Studies
por: Sofat, Reecha, et al.
Publicado: (2016)

Shared parameter model for competing risks and different data summaries in meta‐analysis: Implications for common and rare outcomes
por: Thom, Howard, et al.
Publicado: (2019)

Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis
por: Skapinakis, Petros, et al.
Publicado: (2016)

Adjusting trial results for biases in meta‐analysis: combining data‐based evidence on bias with detailed trial assessment
por: Rhodes, K. M., et al.
Publicado: (2019)

The choice between hip prosthetic bearing surfaces in total hip replacement: a protocol for a systematic review and network meta-analysis
por: Marques, Elsa M. R., et al.
Publicado: (2016)

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
por: Hingorani, Aroon D, et al.
Publicado: (2023)

A new large-scale meta-epidemiological study on bias in randomized trials using routinely collected risk-of-bias assessments by cochrane reviewers: results from the robes study
por: Savovic, Jelena, et al.
Publicado: (2015)

Improving the odds of drug development success through human genomics: modelling study
por: Hingorani, Aroon D., et al.
Publicado: (2019)

Choice of implant combinations in total hip replacement: systematic review and network meta-analysis
por: López-López, José A, et al.
Publicado: (2017)

A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service
por: Kuan, Valerie, et al.
Publicado: (2019)

Selecting instruments for Mendelian randomization in the wake of genome-wide association studies
por: Swerdlow, Daniel I, et al.
Publicado: (2016)

Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies
por: Page, Matthew J., et al.
Publicado: (2016)

Data-driven identification of ageing-related diseases from electronic health records
por: Kuan, Valerie, et al.
Publicado: (2021)

Drug and therapeutics committees as guardians of safe and rational medicines use
por: Sofat, Reecha, et al.
Publicado: (2019)

Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom
por: Chung, Sheng-Chia, et al.
Publicado: (2020)

Extending Treatment Networks in Health Technology Assessment: How Far Should We Go?
por: Caldwell, Deborah M., et al.
Publicado: (2015)

Erratum to: Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling
por: Thom, Howard, et al.
Publicado: (2017)

Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling
por: Thom, Howard, et al.
Publicado: (2017)

Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study
por: Savović, Jelena, et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events
por: Keeney, Edna, et al.
Publicado: (2021)

Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta‐analysis of randomized controlled trials
por: Thomas, Kyla H., et al.
Publicado: (2021)

Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT
por: Hollingworth, William, et al.
Publicado: (2019)

Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
por: Savović, Jelena, et al.
Publicado: (2014)

ROBIS: A new tool to assess risk of bias in systematic reviews was developed
por: Whiting, Penny, et al.
Publicado: (2016)

Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
por: Jørgensen, Lars, et al.
Publicado: (2016)

Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort study
por: Olvera-Barrios, Abraham, et al.
Publicado: (2023)

Automated methods to test connectedness and quantify indirectness of evidence in network meta‐analysis
por: Thom, Howard, et al.
Publicado: (2018)

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
por: Naci, Huseyin, et al.
Publicado: (2019)

The urgent need to move upstream in caring for people with rheumatic and musculoskeletal diseases
por: Bouraoui, Aicha, et al.
Publicado: (2022)

Probability of encountering Covid-19 patients based on prevalence and testing during resumption of ophthalmology services
por: Keller, Johannes, et al.
Publicado: (2020)

Evidence Synthesis for Decision Making 7: A Reviewer’s Checklist
por: Ades, A. E., et al.
Publicado: (2013)

Evidence Synthesis for Decision Making 4: Inconsistency in Networks of Evidence Based on Randomized Controlled Trials
por: Dias, Sofia, et al.
Publicado: (2013)

C-Reactive Protein and Prognosis in Diabetes: Getting to the Heart of the Matter
por: Sattar, Naveed, et al.
Publicado: (2009)

Cost-effectiveness and value of information analysis of a low-friction environment following skin graft in patients with burn injury
por: Kandiyali, Rebecca, et al.
Publicado: (2020)

Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
por: Gordillo-Marañón, María, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2a2337mplvcv8l3h279fecnpjj